Recurrent Ovarian Carcinoma Recruiting Phase 3 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0030000 (Recurrent Ovarian Carcinoma)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03598270Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian CancerTreatment
NCT03690739Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian CancerPrevention
NCT04201561High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral NeuropathyPrevention